Fabian Finkelmeier
Goethe University Frankfurt(DE)Cardiovascular Center Bethanien(DE)University Hospital Frankfurt(DE)Frankfurt Cancer Institute(DE)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Liver Disease Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Hepatitis C virus research
Most-Cited Works
- → NASH limits anti-tumour surveillance in immunotherapy-treated HCC(2021)1,187 cited
- → Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial(2023)380 cited
- → Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis(2017)340 cited
- → Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score(2021)286 cited
- → A faecal microbiota signature with high specificity for pancreatic cancer(2022)267 cited
- → Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade(2023)225 cited